Skip to Content

Join the 'Opioid' group to help and get support from people like you.

Opioid News

Narcan (naloxone HCl) Nasal Spray 2mg Approved by U.S. Food and Drug Administration

Posted 6 Feb 2017 by Drugs.com

January 25, 2017 – Dublin, Ireland – Today, the U.S. Food and Drug Administration (FDA) approved Narcan Nasal Spray as a 2mg formulation for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. The 2mg dose is approved for use in opioid-dependent patients expected to be at risk for severe opioid withdrawal in sit ...

Collegium Receives FDA Approval for Xtampza ER, an Analgesic with Abuse-Deterrent Properties

Posted 30 Apr 2016 by Drugs.com

CANTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) – Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) approved Xtampza ER (oxycodone) extended-release (ER) capsules CII, a twice-daily, oxycodone medication for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative ...

Ask a Question